The assessment of the fraction of a circulating hormone that is unbound to carrier proteins, thus capable of interacting with cellular receptors to elicit a biological response. Total hormone concentration often provides an incomplete clinical picture regarding actual tissue effect. Accurate measurement of this free fraction is crucial for diagnosing functional endocrine states.
Origin
Stemming from analytical biochemistry and endocrinology, the need arose because protein binding affinity varies significantly between hormones like testosterone and estradiol. This distinction separates mere circulation from physiological activity. It represents a refinement over older assays focused only on total mass.
Mechanism
Measurement protocols typically involve equilibrium dialysis or highly specific immunoassays designed to quantify only the unbound fraction. This unbound fraction directly governs the rate of receptor binding and subsequent genomic or non-genomic signaling events. Higher bioavailable levels correlate directly with expected target tissue response and clinical efficacy.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.